Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: Results of the cystic fibrosis related diabetes therapy trial

Diabetes Care

Volumn 32, Issue 10, 2009, Pages 1783-1788

  Moran, Antoinette ^a   Pekow, Penelope ^b   Grover, Patricia ^a   Zorn, Martha ^b   Slovis, Bonnie ^c   Pilewski, Joseph ^d   Tullis, Elizabeth ^e   Liou, Theodore G ^f   Allen, Holley ^g  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f UNIVERSITY OF UTAH   (United States)

^g BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN ASPART; PLACEBO; REPAGLINIDE;

ADULT; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DIET RESTRICTION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; FEMALE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

ADULT; BODY MASS INDEX; CYSTIC FIBROSIS; DIABETES MELLITUS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE;

EID: 70349684926     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-0585     Document Type: Article

References (24)

1. Moran A, Doherty L, Wang X, Thomas W. Abnormal glucose metabolism in cystic fibrosis. J Pediatr 1998;133:10-16 (Pubitemid 28323899)
2. Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, Brunzell C, Campbell PW, Chesrown SE, Duchow C, Fink RJ, FitzSimmons SC, Hamilton N, Hirsch I, Howenstine MS, Klein DJ, Madhun Z, Pencharz PB, Quittner AL, Robbins MK, Schindler T, Schissel K, Schwarzenberg SJ, Stallings VA, Tullis DE, Zipf WB. Diagnosis, screening, and management of CFRD: a consensus conference report. J Diabetes Res Clin Pract 1999;45:55-71
3. Schwarzenberg SJ, Thomas W, Olsen TW, Grover T, Walk D, Milla CE, Moran A. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 2007;30:1056-1061 (Pubitemid 46684624)
4. Moran A, Milla C, DuCret R, Nair KS. Protein metabolism in clinically stable adult CF patients with abnormal glucose tolerance. Diabetes 2001;50:1336-1343 (Pubitemid 32500166)
5. Moran A, Basu R, Milla C, Jensen M. Insulin regulation of free fatty acid kinetics in adult cystic fibrosis patients with impaired glucose tolerance. Metabolism 2004;53:1467-1472 (Pubitemid 39410388)
6. Hardin DS, Leblanc A, Lukenbaugh S, Para L, Seilheimer DK. Proteolysis associated with insulin resistance in cystic fibrosis. Pediatrics 1998;101:433-437 (Pubitemid 28136419)
7. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in cystic fibrosis patients correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2001;162:891-895
8. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41:583-591 (Pubitemid 18158831)
9. Snell GI, Bennetts K, Bartolo J, Levvey B, Griffiths A, Williams T, Rabinov M. Body mass index as a predictor of survival in adults with cystic fibrosis referred for lung transplantation. J Heart Lung Transplant 1998;17:1097-1103 (Pubitemid 28547278)
10. Kerem E, Reisman J, Corey M, Canny GC, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326:1187-1191
11. Taussig LM, Kattwinkel J, Friedewald WT, di Sant'Agnese PA. A new prognostic score and clinical evaluation system for cystic fibrosis. J Pediatr 1973;82:380-390
12. Sockrider MM, Swank MR, Seilheimer DK, Schidlow DV. Measuring clinical status in cystic fibrosis: internal validity and reliability of a modified NIH score. Pediatr Pulmonol 1994;17:86-96
13. Modi AC, Quittner AL. Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. J Pediatr Psychol 2003;28:535-546
14. Kettler LJ, Sawyer SM, Winefield HR, Greville HW. Determinants for adherence in adults with cystic fibrosis. Thorax 2002;57:459-464 (Pubitemid 34494161)
15. Lanng S, Thorsteinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr 1994;83:849-853 (Pubitemid 24281615)
16. Rolon MA, Benali K, Munck A, Navarro J, Clement A, Tubina-Rufi N, Paul C, Polzk M. CFRD: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001;90:860-867
17. Nousia-Arvanitakis S, Galli-Tsinopoulou A, Karamouzis M. Insulin improves clinical status of patients with cystic fibrosis-related diabetes mellitus. Acta Paediatr 2001;90:515-519 (Pubitemid 32552133)
18. Mohan K, Israel KL, Miller H, Grainger R, Ledson MJ, Walshaw MJ. Long-term effect of insulin treatment in cystic fibrosis-related diabetes. Respiration 2008;76:181-186
19. Mozzillo E, Franzese A, Valerio G, Sepe A, De Simone I, Mazzarella G, Ferri P, Raia V. One year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements. Pediatr Diabetes 2009;10:162-167
20. Bizzarri C, Lucidi V, Ciampalini P, Bella S, Russo B, Cappa M. Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance. J Endocrinol Invest 2006;29:1-4
21. Moran A, Phillips J, Milla C. Insulin and glucose excursion following pre-meal insulin lispro or repaglinide in cystic fibrosis related diabetes. Diabetes Care 2001;24:1706-1710 (Pubitemid 33716470)
22. Alvarsson M, Sundkivst G, lager I, Hernricksson M, Berntorp K, Fernqvist-Forbes E, Steen L, Westermark G, Westermark P, Orn T, Grill V. Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients. Diabetes Care 2003;26:2231-2237
23. Maedler K, Carr R, Bosco D, R. Z., Berney T, Donath MY. Sulfonylurea induced β-cell apoptosis in cultured human islets. J Clin Endocrinol Metab 2005;90:501-506 (Pubitemid 40116700)
24. Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005;28:2141-2144 (Pubitemid 41242458)